Cherevka Holli 4
4 · Ampio Pharmaceuticals, Inc. · Filed May 25, 2021
Insider Transaction Report
Form 4
Cherevka Holli
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-21$0.51/sh+2,603$1,328→ 2,603 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-21−2,603→ 152,766 totalExercise: $0.51Exp: 2029-09-16→ Common Stock (2,603 underlying) - Sale
Common Stock
2021-05-21$2.00/sh−2,603$5,206→ 0 total
Footnotes (2)
- [F1]The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 12, 2021.
- [F2]Options were granted and previously reported on a Form 4 filed on September 18, 2019, where 50% of the options awarded vested and became exercisable on the grant date of September 16, 2019 and the other 50% of the options awarded vested and became exercisable on the first anniversary of the grant date.